skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Búsqueda Sencilla
Refinado por: Título de revista: Annals Of Oncology eliminar materia: Antineoplastic Combined Chemotherapy Protocols - Adverse Effects eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study
Material Type:
Artículo 		Añadir a Mi Portal

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study

Folprecht, G. ; Pericay, C. ; Saunders, M.P. ; Thomas, A. ; Lopez Lopez, R. ; Roh, J.K. ; Chistyakov, V. ; Höhler, T. ; Kim, J.-S. ; Hofheinz, R.-D. ; Ackland, S.P. ; Swinson, D. ; Kopp, M. ; Udovitsa, D. ; Hall, M. ; Iveson, T. ; Vogel, A. ; Zalcberg, J.R.

Annals of oncology, 2016-07, Vol.27 (7), p.1273-1279 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

Citas Citado por
2
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)
Material Type:
Artículo 		Añadir a Mi Portal

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)

Moehler, M. ; Maderer, A. ; Thuss-Patience, P.C. ; Brenner, B. ; Meiler, J. ; Ettrich, T.J. ; Hofheinz, R.-D. ; Al-Batran, S.E. ; Vogel, A. ; Mueller, L. ; Lutz, M.P. ; Lordick, F. ; Alsina, M. ; Borchert, K. ; Greil, R. ; Eisterer, W. ; Schad, A. ; Slotta-Huspenina, J. ; Van Cutsem, E. ; Lorenzen, S.

Annals of oncology, 2020-02, Vol.31 (2), p.228-235 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

Citas Citado por
3
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel±darbepoetin alfa in primary breast cancer—results at the time of surgery
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel±darbepoetin alfa in primary breast cancer—results at the time of surgery
Material Type:
Artículo 		Añadir a Mi Portal

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel±darbepoetin alfa in primary breast cancer—results at the time of surgery

Untch, M. ; Fasching, P.A. ; Konecny, G.E. ; von Koch, F. ; Conrad, U. ; Fett, W. ; Kurzeder, C. ; Lück, H.-J. ; Stickeler, E. ; Urbaczyk, H. ; Liedtke, B. ; Salat, C. ; Harbeck, N. ; Müller, V. ; Schmidt, M. ; Hasmüller, S. ; Lenhard, M. ; Schuster, T. ; Nekljudova, V. ; Lebeau, A. ; Loibl, S. ; von Minckwitz, G.

Annals of oncology, 2011-09, Vol.22 (9), p.1988-1998 [Revista revisada por pares]

Oxford: Elsevier Ltd

Texto completo disponible

Citas Citado por

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora